Adalimumab Reduces Extraintestinal Manifestations in Patients With Crohn’s Disease: A Pooled Analysis of 11 Clinical Studies
Advances in Therapy - United States
doi 10.1007/s12325-018-0678-0
Full Text
Open PDFAbstract
Available in full text
Date
March 7, 2018
Authors
Publisher
Springer Science and Business Media LLC